First U.S. trial for treatment of novel coronavirus begins in Nebraska  

The first clinical trial for the treatment of novel coronavirus in the U.S has started, the National Institutes of Health (NIH) announced on Tuesday.

The randomized trial includes coronavirus patients admitted at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska. Infected patients have been divided into two groups. While one group would be given an antiviral, others will be put on a placebo.

"A randomized, placebo-controlled trial is the gold standard for determining if an experimental treatment can benefit patients," said Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and U.S. Coronavirus Task Force member. 

Click here for more.